A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)

Trial Profile

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Jan 2017

At a glance

  • Drugs Ulipristal (Primary)
  • Indications Uterine leiomyoma
  • Focus Adverse reactions; Registrational
  • Acronyms PREMYA
  • Sponsors PregLem
  • Most Recent Events

    • 26 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
    • 26 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 17 Dec 2012 New source identified and integrated (United Kingdom Clinical Research Network, 12878).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top